InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.80
(
2.15%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
-1.03%
)
Bitcoin
62,871.24
(
6.34%
)
Post# of 73
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Zardiw

Send PM Follow Ignore
Followers 2499
Posts 109510
Boards Moderated 26
Alias Born 01/09/2001

Zardiw

Member Level

Re: zsvq1p post# 51

Monday, 03/05/2007 12:45:17 PM

Monday, March 05, 2007 12:45:17 PM

Post# of 73
BGTH / ECSI (OTCBB, .20) Bridgetech Acquires Controlling Interest in ECash, Inc. for Its Domestic Operation

SAN DIEGO, March 5, 2007 /PRNewswire via COMTEX/ -- Bridgetech Holdings
International Inc., (BGTH) a company focused on maximizing the potential of
emerging healthcare products and services in China, announces the purchase of a
controlling interest in ECash, Inc. (ECSI) through the merger of our wholly owned
subsidiary, Clarity Imaging International, Inc. (Clarity) and ECash. The purchase
of the controlling interest of ECash is for the sole purpose of separating the
company's Chinese and Domestic healthcare interests. ECash will be comprised
solely of the current business operations of Clarity. The divergence of
Bridgetech's China operations from the domestic operations of Clarity will
provide a focused business strategy for both companies. Michael Chermak, Chairman
and CEO of Bridgetech stated, "This division of our domestic and international
interests strengthens our business and revenue model and will enable Bridgetech
to focus on building its operations and continuing expansion throughout China."
Chermak added that Clarity will focus on growth and expansion domestically. "This
will be a winning combination for all shareholders," he said.

About Bridgetech Holdings International, Inc.

Bridgetech is leveraging its extensive network of relationships in China and the
U.S. to capitalize on the demand for Western healthcare in Greater China. The
company is bringing emerging drugs, devices and diagnostics to Greater China,
with an initial focus on oncology. For additional information, please visit
Bridgetech at http://www.bthi.com and Clarity at http://www.clmd.com

Forward-Looking Statements.

Statements contained in this press release that are not statements of historical
fact are "forward-looking statements" as that term is defined under federal
securities laws, including, without limitation, all statements concerning
expectations, beliefs, goals, intention or strategies for the future of
Bridgetech. Forward-looking statements may be identified by words such as
"goals," "plans," "believes," "will," "expects" and other words of similar
meaning used in conjunction with, among other things, discussions of future
operations, financial performance, product development and new ventures. Many
factors could cause actual events or results to differ materially from those
expressed in any forward-looking statement. Investors are cautioned not to place
any undue reliance on any forward-looking statements.

Contacts:

Media Relations: Vince Heald, Beck Ellman Heald - 858-453-9600
vheald@behmedia.com

Investor Relations: Redwood Consultants, LLC - 415-884-0348

SOURCEBridgetech Holdings International Inc.

Media Relations, Vince Heald of Beck Ellman Heald, +1-858-453-9600,
vheald@behmedia.com, for Bridgetech Holdings International Inc.; or Investor
Relations, Redwood Consultants, LLC, +1-415-884-0348, for Bridgetech Holdings
International Inc.

http://www.bthi.com


z

Do NOT view my Profile!! (i.e. click on zardiw)



Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up